Voyager Therapeutics (VYGR) Tops Q1 EPS by 287c

Voyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of $2.94, $2.87 better than the analyst estimate of $0.07. Revenue for the quarter came in at $150.48 million versus the consensus estimate of $10.04 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Paychex beats fourth quarter EPS estimates, stock slides
• ICON plc (ICLR) PT Raised to $150 at BofA Securities